Clariant short-sellers squeezed as activist Corvex doubles-down

LONDON, Sept 20 (Reuters) - Hedge funds have trimmed bets on a fall in shares of Clariant, just as activist investor Corvex increases pressure on the Swiss chemicals company to ditch a $20 billion M&A deal with rival Huntsman.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.